| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/24/1991 | CA2067491A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
| 04/24/1991 | CA2028246A1 Tricyclic quinoline antineoplastic agents |
| 04/23/1991 | US5010176 Malonate linker |
| 04/23/1991 | US5010097 Collagenase inhibitors, antiarthritic agents |
| 04/23/1991 | US5010062 Therapeutic agent and method of inhibiting vascularization of tumors |
| 04/23/1991 | CA1283359C Compositions of neocarzinostatin derivative for non-injection administration |
| 04/21/1991 | WO1991005546A1 Solid tumor treatment method and composition |
| 04/21/1991 | WO1991005545A1 Liposome microreservoir composition and method |
| 04/21/1991 | CA2028086A1 Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
| 04/21/1991 | CA2028076A1 Synthesis of swainsonine and analogs thereof |
| 04/21/1991 | CA2028024A1 Tumor-associated antigen |
| 04/18/1991 | WO1991004985A1 Dehydrodidemnin b |
| 04/18/1991 | WO1991004755A1 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 04/18/1991 | WO1991004754A2 Illudin analogs as anti-tumor agents |
| 04/18/1991 | WO1991004748A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 04/18/1991 | WO1991004739A1 Use of prostacyclin derivatives against metastases |
| 04/18/1991 | CA2027792A1 Water and solvent soluble axial hydroxy and mono- and di-carboxylic acid derivatives having high tumor activity |
| 04/18/1991 | CA2027725A1 Use of a polypeptide with human interleukin-2 activity for preparation of pharmaceutical compositions used in leukemia treatment |
| 04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
| 04/17/1991 | EP0422051A1 Condensed pyrazole 3-oxo-propanenitrile derivatives and process for their preparation |
| 04/17/1991 | EP0422010A1 Combination therapy of il-2 and dtic for the treatment of melanoma |
| 04/17/1991 | EP0416033A4 Macrocyclic chelates and methods of use thereof |
| 04/17/1991 | EP0235151B1 Proglumide and pharmaceutical compositions containing it for use in the treatment of neoplastic affections |
| 04/17/1991 | CN1050719A Epiopodophyllotoxin altroside derivatives |
| 04/17/1991 | CA2267658A1 Use of stem cell factor polypeptide to stimulate growth of epithelial cells |
| 04/17/1991 | CA2267643A1 Use of stem cell factor polypeptide as an anti-hematopoietic disorder agent |
| 04/17/1991 | CA2267626A1 Use of stem cell factor polypeptide to stimulate growth of stromal cells |
| 04/16/1991 | US5008374 IL-1α derivatives and drugs |
| 04/16/1991 | US5008294 Topical administration |
| 04/16/1991 | US5008287 Pharmaceutical compositions having antineoplastic activity |
| 04/16/1991 | US5008283 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| 04/16/1991 | CA1283046C Tumor necrosis factor formulation |
| 04/14/1991 | WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/14/1991 | CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same |
| 04/13/1991 | WO1991005791A1 Gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them |
| 04/13/1991 | CA2067191A1 Gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them |
| 04/10/1991 | EP0421876A1 Use of active agents in the preparation of a drug for the treatment of lymphomes or related diseases |
| 04/10/1991 | EP0421562A2 Use of prostacyclin analogs against metastases |
| 04/10/1991 | EP0421561A2 24-D-homo-vitamin D-derivatives, a process for their production, pharmaceutical compositions containing them and their use as medicines |
| 04/10/1991 | EP0421380A1 Tumor-lysing cell inducer, method for inducing tumor-lysing cell and device for inducing tumor-lysing cell |
| 04/10/1991 | EP0421364A2 Pleuromutilins |
| 04/10/1991 | EP0420942A1 Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| 04/10/1991 | EP0420871A1 Method and compositions for treatment of parkinsonism syndrome in mammals |
| 04/10/1991 | EP0420849A1 Use of sucralfate |
| 04/10/1991 | CN1050503A Stabilized leukocyte-interferons |
| 04/09/1991 | US5006652 Intermediates for antibody-vinca drug conjugates |
| 04/09/1991 | US5006551 Composition for destroying malignant tumors |
| 04/09/1991 | US5006515 Immunology disorders, antitumor agent |
| 04/09/1991 | CA1282779C Polysaccharide ron substance, production of the same and use of the same |
| 04/07/1991 | WO1991005536A2 Novel oxidized lipoproteins and methods for their preparation |
| 04/07/1991 | WO1991004744A1 Methods and apparatus for treating disease states using oxidized lipoproteins |
| 04/07/1991 | CA2067364A1 Oxidized lipoproteins and methods for their preparation |
| 04/07/1991 | CA2067356A1 Methods for treating diseases using oxidized lipoproteins |
| 04/07/1991 | CA2027077A1 Application of active substances for the preparation of a drug for the treatment of lymphomas or related diseases, the drugs thus obtained and a process for the therapeutic treatment of lymphomas |
| 04/04/1991 | WO1991004053A1 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells |
| 04/04/1991 | WO1991004037A1 Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
| 04/04/1991 | WO1991004033A1 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents |
| 04/04/1991 | WO1991004028A1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 04/04/1991 | WO1991001744A3 Uses of interleukin-4 and method for purifying it |
| 04/04/1991 | WO1991000289A3 Targeted liposomes and methods for liposome-protein coupling |
| 04/03/1991 | EP0420193A2 Use of hydroxyurea or 1-ethyl-hydroxyurea for the suppression of bone marrow cells before transplantation |
| 04/03/1991 | EP0420121A1 Antitumor composition |
| 04/03/1991 | EP0420049A1 Stabilized leucocyte-interferon |
| 04/03/1991 | EP0419890A2 Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method |
| 04/03/1991 | EP0419653A1 Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
| 04/03/1991 | EP0419535A1 Platinum-polymer complexes and their use as antitumor agents. |
| 04/03/1991 | EP0419501A1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components. |
| 04/03/1991 | CN1050385A Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity |
| 04/02/1991 | US5004811 Tetrapyrrole aminocarboxylic acids |
| 04/02/1991 | US5004758 Nontoxic; activity against leukemia |
| 04/02/1991 | US5004756 Anti-cancer activity potentiator |
| 04/02/1991 | US5004735 Pharmaceutical compositions for the inhibition of tumor metastasis |
| 04/02/1991 | US5004692 Pure DNA segment for producing large quantities of clostridium phospholipase polypeptides |
| 04/02/1991 | US5004681 Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
| 04/02/1991 | CA1282338C 5 .alpha.-REDUCTASE INHIBITOR |
| 03/30/1991 | CA2025155A1 Extracellular exopolymer, process for its preparation and pharmaceutical compositions containing the said exopolymer |
| 03/29/1991 | CA2024046A1 Stabilized leukocyte-interferons |
| 03/28/1991 | DE3936594A1 (gamma)-glutamyl-transferasen zur behandlung von krankheiten (Gamma) glutamyl-transferases for treating diseases |
| 03/28/1991 | CA2025857A1 Antitumor composition |
| 03/28/1991 | CA2023930A1 Method for the suppression of bone marrow |
| 03/27/1991 | EP0419387A1 Hydrophilic derivatives, diagnostic and therapeutic applications, kits and immunological reagents |
| 03/27/1991 | EP0419132A2 Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 03/27/1991 | EP0419131A2 Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 03/27/1991 | EP0418924A2 Pyrrolopyrimidines, their production and use |
| 03/27/1991 | EP0418655A2 Conjugated gamma-hydroxybutenolide compounds and antiulcer agents containing the same as an effective ingredient |
| 03/27/1991 | EP0418292A1 Phosphoramides useful as antitumor agents |
| 03/27/1991 | EP0418233A1 Cysteine proteinase inhibitor |
| 03/27/1991 | EP0418230A1 Method for potentiating and inhibiting insulin-like growth factor activity. |
| 03/27/1991 | CN1050198A Peptidase and isomerase inhibitors |
| 03/27/1991 | CN1012174B Method for preparing novel 4'-demethy 1-4-epipodophyllotoxin derivatives |
| 03/27/1991 | CA2026128A1 Imidazolepropanamide derivatives, preparation and use |
| 03/26/1991 | WO1991004048A1 Therapeutic agent and method of inhibiting vascularization of tumors |
| 03/26/1991 | US5002969 Pharmaceutical compositions containing titanocene complexes and use of these complexes as cytostatic agents |
| 03/26/1991 | US5002962 Porphyrins |
| 03/26/1991 | US5002959 Antitumor agents, fungicides |
| 03/26/1991 | US5002954 Leukemia, melanoma |
| 03/26/1991 | US5002952 Benzoylurea Antitumor Agents |
| 03/26/1991 | US5002931 Human Hypothalmic Growth Hormone Releasing Factor |
| 03/26/1991 | US5002753 Z Isomers, Halovinyl Substituents |
| 03/26/1991 | CA1282060C Tetrahydro-3,4-furandiamine-n,n'-platinum complexes |